XML 39 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net income $ 188 $ 269 $ 147
Add (deduct) adjustments to reconcile net income to net cash flows from operating activities      
Depreciation, amortization and accretion 895 909 932
Bad debts expense 60 77 112
Stock-based compensation expense 49 53 59
Deferred income taxes, net 52 190 34
Equity in earnings of unconsolidated entities (182) (181) (168)
Distributions from unconsolidated entities 180 189 162
(Gain) loss on asset disposals, net 26 27 12
(Gain) loss on sale of business and other exit costs, net (2) 0 (1)
(Gain) loss on license sales and exchanges, net 0 (5) 0
(Gain) loss on investments 0 (2) 0
Other operating activities 61 3 4
Changes in assets and liabilities from operations      
Accounts receivable (22) (16) (49)
Equipment installment plans receivable (116) (54) (97)
Inventory (25) 12 (19)
Accounts payable (69) 173 (60)
Customer deposits and deferred revenues 43 4 (9)
Accrued taxes (49) (120) (17)
Other assets and liabilities 14 4 (26)
Net cash provided by operating activities 1,103 1,532 1,016
Cash flows from investing activities      
Cash paid for additions to property, plant and equipment (1,131) (1,338) (957)
Cash paid for acquisitions, licenses and other intangible assets (1,308) (172) (346)
Cash received from investments 3 1 29
Cash paid for investments 0 (3) (11)
Cash received from divestitures and exchanges 3 26 41
Advance payments for license acquisitions (20) (30) (5)
Other investing activities (9) 5 0
Net cash used in investing activities (2,462) (1,511) (1,249)
Cash flows from financing activities      
Issuance of long-term debt 1,543 1,250 0
Repayment of long-term debt (2,081) (110) (118)
Issuance of TDS Preferred Shares 1,110 0 0
TDS Common Shares reissued for benefit plans, net of tax payments (5) (3) (6)
UScellular Common Shares reissued for benefit plans, net of tax payments (16) (11) (9)
Repurchase of TDS Common Shares (8) (14) 0
Repurchase of UScellular Common Shares (31) (23) (21)
Dividends paid to TDS shareholders (119) (78) (75)
Payment of debt and equity issuance costs (62) (41) (1)
Distributions to noncontrolling interests (3) (2) (4)
Payments to acquire additional interest in subsidiaries 0 (11) 0
Other financing activities (7) 0 14
Net cash provided by (used in) financing activities 321 957 (220)
Net increase (decrease) in cash, cash equivalents and restricted cash (1,038) 978 (453)
Cash, cash equivalents and restricted cash      
Beginning of period 1,452 474 927
End of period $ 414 $ 1,452 $ 474